Details of the Drug Combination
General Information of Drug Combination (ID: DCQLH1N)
Drug Combination Name |
BIIB-021 Parthenolide
|
|||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Indication |
|
|||||||||||||||||
Component Drugs | BIIB-021 | Parthenolide | ||||||||||||||||
Small molecular drug | Small molecular drug | |||||||||||||||||
2D MOL | 2D MOL | |||||||||||||||||
3D MOL | 3D MOL | |||||||||||||||||
High-throughput Screening Result | Testing Cell Line: SU-DIPG-XIII | |||||||||||||||||
Zero Interaction Potency (ZIP) Score: 12.928 | ||||||||||||||||||
Bliss Independence Score: 12.842 | ||||||||||||||||||
Loewe Additivity Score: 0.439 | ||||||||||||||||||
LHighest Single Agent (HSA) Score: 3.316 | ||||||||||||||||||
Molecular Interaction Atlas of This Drug Combination
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Indication(s) of BIIB-021 |
|
||||||||||||||||||||||||||||||
BIIB-021 Interacts with 1 DTT Molecule(s)
|
|||||||||||||||||||||||||||||||
Parthenolide Interacts with 2 DTT Molecule(s)
|
|||||||||||||||||||||||||||||||
References